GlassScriptPhysician profile
Lyndsey Whitaker
NPI 1295292332
$2,749.68
in general payments reported to CMS, 2019-2025
18 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $12.47 · 2023: $18.10 · 2024: $1,025 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.48 |
| Education | $108.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $687.91 | 2024-2025 | |
| Genzyme Corporation | $423.50 | 2024-2025 | |
| Lilly USA, LLC | $399.39 | 2024-2025 | Taltz, Ebglyss, Zepbound |
| Janssen Biotech, INC. | $324.76 | 2024-2025 | Tremfya, Simponi Aria |
| Leo Pharma INC. | $239.89 | 2024-2025 | Adbry, Anzupgo |
| Ucb, INC. | $125.83 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $106.84 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $99.88 | 2024-2025 | |
| Amgen INC. | $94.47 | 2024-2025 | Otezla, Otezla |
| Redhill Biopharma INC. | $68.84 | 2021 | |
| Novo Nordisk INC | $47.45 | 2021-2023 | |
| Biofrontera INC. | $39.28 | 2024-2025 | Ameluz, Rhodoled Xl, Xepi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.39 | 2024 | Siliq |
| Pfizer INC. | $19.49 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $19.20 | 2024 | Libtayo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $14.45 | 2021 | |
| Endo Pharmaceuticals INC. | $13.12 | 2021 | |
| Organon LLC | $4.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyndsey Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.